Skip to main content
. 2022 Apr 8;13(10):1479–1489. doi: 10.1111/1759-7714.14417

FIGURE 3.

FIGURE 3

(a) Analysis of PFS and (b) OS by key clinical factors of body mass index. Ad, adenocarcinoma; BMI, body mass index; CI, confidence interval; ECOG‐PS, Eastern Cooperative Oncology Group‐performance status; GPS, Glasgow prognostic score; PFS, progression‐free survival; rec, recurrence; RT, radiotherapy